` 002424 (Guizhou Bailing Group Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

G
002424
vs
S
Shanghai Composite

Over the past 12 months, Guizhou Bailing Group Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +13% compared to the Shanghai Composite's +24% growth.

Stocks Performance
002424 vs Shanghai Composite

Loading
002424
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
002424 vs Shanghai Composite

Performance Gap Between 002424 and SSEC
HIDDEN
Show

Performance By Year
002424 vs Shanghai Composite

Loading
002424
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Guizhou Bailing Group Pharmaceutical Co Ltd vs Peers

Shanghai Composite
002424
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Guizhou Bailing Group Pharmaceutical Co Ltd
Glance View

Market Cap
6.1B CNY
Industry
Pharmaceuticals

Guizhou Bailing Group Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicines. The company is headquartered in Anshun, Guizhou and currently employs 6,124 full-time employees. The company went IPO on 2010-06-03. The firm is also engaged in the provision of Chinese medicine materials. The firm is also engaged in the distribution of fertilizers and purified water, and the operation of medical institutions. The firm conducts its businesses mainly within domestic markets.

Guizhou Bailing Group Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top